These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419 [TBL] [Abstract][Full Text] [Related]
8. Toward a core nutraceutical program for cancer management. McCarty MF; Block KI Integr Cancer Ther; 2006 Jun; 5(2):150-71. PubMed ID: 16685077 [TBL] [Abstract][Full Text] [Related]
9. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol. Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020 [TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic function of tocotrienol. Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349 [TBL] [Abstract][Full Text] [Related]
11. Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3. Hu-Lowe DD; Zou HY; Grazzini ML; Hallin ME; Wickman GR; Amundson K; Chen JH; Rewolinski DA; Yamazaki S; Wu EY; McTigue MA; Murray BW; Kania RS; O'Connor P; Shalinsky DR; Bender SL Clin Cancer Res; 2008 Nov; 14(22):7272-83. PubMed ID: 19010843 [TBL] [Abstract][Full Text] [Related]
12. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor. Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496 [TBL] [Abstract][Full Text] [Related]
13. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341 [TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor. Kong D; Okamura M; Yoshimi H; Yamori T Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509 [TBL] [Abstract][Full Text] [Related]
15. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Nicoli S; Ribatti D; Cotelli F; Presta M Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396 [TBL] [Abstract][Full Text] [Related]
16. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies. Shojaei F; Ferrara N Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057 [TBL] [Abstract][Full Text] [Related]
17. Preadministration of high-dose salicylates, suppressors of NF-kappaB activation, may increase the chemosensitivity of many cancers: an example of proapoptotic signal modulation therapy. McCarty MF; Block KI Integr Cancer Ther; 2006 Sep; 5(3):252-68. PubMed ID: 16880431 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiogenesis by vitamin D-binding protein: characterization of anti-endothelial activity of DBP-maf. Kalkunte S; Brard L; Granai CO; Swamy N Angiogenesis; 2005; 8(4):349-60. PubMed ID: 16400520 [TBL] [Abstract][Full Text] [Related]
19. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. Jung MH; Lee SH; Ahn EM; Lee YM Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635 [TBL] [Abstract][Full Text] [Related]
20. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Kunnumakkara AB; Diagaradjane P; Guha S; Deorukhkar A; Shentu S; Aggarwal BB; Krishnan S Clin Cancer Res; 2008 Apr; 14(7):2128-36. PubMed ID: 18381954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]